
Piramal Pharma Limited has informed the Exchange regarding a press release dated December 18, 2023, titled "Intimation of a Press Release regarding opening of Antibody-Drug Conjugate ( ADC ) manufacturing expansion in Grangemouth, Scotland".
Filed with NSE ·

Piramal Pharma Limited has informed the Exchange regarding a press release dated December 18, 2023, titled "Intimation of a Press Release regarding opening of Antibody-Drug Conjugate ( ADC ) manufacturing expansion in Grangemouth, Scotland".
6ix hasn’t read this filing yet.
Follow Piramal Pharma into a list and get an email when it puts out news.
Follow Piramal Pharma